Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA

ACS Chemical Biology

Volumn 6, Issue 9, 2011, Pages 962-970

  Ma, Yuelong ^a   Kowolik, Claudia M ^a   Swiderski, Piotr M ^a   Kortylewski, Marcin ^a   Yu, Hua ^a   Horne, David A ^a   Jove, Richard ^a   Caballero, Otavia L ^b   Simpson, Andrew J G ^b   Lee, Fook Thean ^c   Pillay, Vinochani ^c   Scott, Andrew M ^c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ARGININE; CHLOROQUINE; LEWIS Y ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HU3S193; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL PROLIFERATION; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; GENE SILENCING; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80053613142     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb200176v     Document Type: Article

References (54)

1. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discovery 8, 129-138
2. Tiemann, K. and Rossi, J. J. (2009) RNAi-based therapeutics-current status, challenges and prospects EMBO Mol. Med. 1, 142-151
3. Jinek, M. and Doudna, J. A. (2009) A three-dimensional view of the molecular machinery of RNA interference Nature 457, 405-412
4. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391, 806-811 (Pubitemid 28099681)
5. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411, 494-498 (Pubitemid 32494397)
6. Caplen, N. J., Parrish, S., Imani, F., Fire, A., and Morgan, R. A. (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems Proc. Natl. Acad. Sci. U.S.A. 98, 9742-9747 (Pubitemid 32769374)
7. Amarzguioui, M., Lundberg, P., Cantin, E., Hagstrom, J., Behlke, M. A., and Rossi, J. J. (2006) Rational design and in vitro and in vivo delivery of Dicer substrate siRNA Nat. Protoc. 1, 508-517
8. Perkel, J. M. (2009) RNAI therapeutics: A two-year update Science 326, 454
9. Davis, M. E. (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharm. 6, 659-668
10. White, P. J. (2008) Barriers to successful delivery of short interfering RNA after systemic administration Clin. Exp. Pharmacol. Physiol. 35, 1371-1376
11. Tseng, Y. C., Mozumdar, S., and Huang, L. (2009) Lipid-based systemic delivery of siRNA Adv. Drug Delivery Rev. 61, 721-731
12. Ikeda, Y. and Taira, K. (2006) Ligand-targeted delivery of therapeutic siRNA Pharm. Res. 23, 1631-1640 (Pubitemid 44200525)
13. Jeong, J. H., Mok, H., Oh, Y. K., and Park, T. G. (2009) siRNA conjugate delivery systems Bioconjugate Chem. 20, 5-14
14. Liu, B. (2007) Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA Briefings Funct. Genomic Proteomic 6, 112-119 (Pubitemid 351721074)
15. Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., Marasco, W. A., and Lieberman, J. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23, 709-717 (Pubitemid 41716361)
16. Kumar, P., Ban, H. S., Kim, S. S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., Yang, Y. G., Jeong, J. H., Lee, K. Y., Kim, Y. H., Kim, S. W., Peipp, M., Fey, G. H., Manjunath, N., Shultz, L. D., Lee, S. K., and Shankar, P. (2008) T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice Cell 134, 577-586
17. Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., and Chang, E. H. (2007) Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system Cancer Res. 67, 2938-2943 (Pubitemid 46724828)
18. Xia, C. F., Boado, R. J., and Pardridge, W. M. (2009) Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology Mol. Pharm. 6, 747-751
19. Scott, A. M., Geleick, D., Rubira, M., Clarke, K., Nice, E. C., Smyth, F. E., Stockert, E., Richards, E. C., Carr, F. J., Harris, W. J., Armour, K. L., Rood, J., Kypridis, A., Kronina, V., Murphy, R., Lee, F. T., Liu, Z., Kitamura, K., Ritter, G., Laughton, K., Hoffman, E., Burgess, A. W., and Old, L. J. (2000) Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors Cancer Res. 60, 3254-3261 (Pubitemid 30407925)
20. Sakamoto, J., Furukawa, K., Cordon-Cardo, C., Yin, B. W., Rettig, W. J., Oettgen, H. F., Old, L. J., and Lloyd, K. O. (1986) Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines Cancer Res. 46, 1553-1561 (Pubitemid 16048313)
21. Kim, Y. S., Yuan, M., Itzkowitz, S. H., Sun, Q. B., Kaizu, T., Palekar, A., Trump, B. F., and Hakomori, S. (1986) Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues Cancer Res. 46, 5985-5992 (Pubitemid 17178016)
22. Dettke, M., Palfi, G., and Loibner, H. (2000) Activation-dependent expression of the blood group-related lewis Y antigen on peripheral blood granulocytes J. Leukocyte Biol. 68, 511-514
23. Zhang, S., Zhang, H. S., Cordon-Cardo, C., Reuter, V. E., Singhal, A. K., Lloyd, K. O., and Livingston, P. O. (1997) Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens Int. J. Cancer 73, 50-56 (Pubitemid 27445990)
24. Scott, A. M., Tebbutt, N., Lee, F. T., Cavicchiolo, T., Liu, Z., Gill, S., Poon, A. M., Hopkins, W., Smyth, F. E., Murone, C., MacGregor, D., Papenfuss, A. T., Chappell, B., Saunder, T. H., Brechbiel, M. W., Davis, I. D., Murphy, R., Chong, G., Hoffman, E. W., and Old, L. J. (2007) A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen Clin. Cancer Res. 13, 3286-3292 (Pubitemid 46944914)
25. Kelly, M. P., Lee, F. T., Tahtis, K., Smyth, F. E., Brechbiel, M. W., and Scott, A. M. (2007) Radioimmunotherapy with alpha-particle emitting 213 Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy Clin. Cancer Res. 13, 5604s-5612s (Pubitemid 47510394)
26. Boghaert, E. R., Sridharan, L., Armellino, D. C., Khandke, K. M., DiJoseph, J. F., Kunz, A., Dougher, M. M., Jiang, F., Kalyandrug, L. B., Hamann, P. R., Frost, P., and Damle, N. K. (2004) Antibody-targeted chemotherapy with the calicheamicin conjugate hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazide targets Lewisy and eliminates Lewisy-positive human carcinoma cells and xenografts Clin. Cancer Res. 10, 4538-4549 (Pubitemid 38878898)
27. Yu, H. and Jove, R. (2004) The STATs of cancer-new molecular targets come of age Nat. Rev. Cancer 4, 97-105 (Pubitemid 38198738)
28. Yu, H., Pardoll, D., and Jove, R. (2009) STATs in cancer inflammation and immunity: a leading role for STAT3 Nat. Rev. Cancer 9, 798-809
29. Jing, N. and Tweardy, D. J. (2005) Targeting Stat3 in cancer therapy Anticancer Drugs 16, 601-607 (Pubitemid 40863092)
30. Yue, P. and Turkson, J. (2009) Targeting STAT3 in cancer: how successful are we? Expert Opin. Investig. Drugs 18, 45-56
31. Al Zaid Siddiquee, K. and Turkson, J. (2008) STAT3 as a target for inducing apoptosis in solid and hematological tumors Cell Res. 18, 254-267 (Pubitemid 351206162)
32. Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., Kalvakolanu, D. V., Kopecko, D. J., Zhao, X., and Xu, D. Q. (2005) Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo Clin. Cancer Res. 11, 6333-6341 (Pubitemid 41262965)
33. Konnikova, L., Kotecki, M., Kruger, M. M., and Cochran, B. H. (2003) Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells BMC Cancer 3, 23
34. Ling, X. and Arlinghaus, R. B. (2005) Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice Cancer Res. 65, 2532-2536 (Pubitemid 40490046)
35. Sumita, N., Bito, T., Nakajima, K., and Nishigori, C. (2006) Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines Exp. Dermatol. 15, 291-299 (Pubitemid 43349070)
36. Lee, S. O., Lou, W., Qureshi, K. M., Mehraein-Ghomi, F., Trump, D. L., and Gao, A. C. (2004) RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells Prostate 60, 303-309 (Pubitemid 39050649)
37. Gao, L. F., Wen, L. J., Yu, H., Zhang, L., Meng, Y., Shao, Y. T., Xu, D. Q., and Zhao, X. J. (2006) Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo Acta Pharmacol. Sin. 27, 347-352 (Pubitemid 43357032)
38. Qiu, Z., Huang, C., Sun, J., Qiu, W., Zhang, J., Li, H., Jiang, T., Huang, K., and Cao, J. (2007) RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells Cancer Sci. 98, 1099-1106 (Pubitemid 46865397)
39. Zhang, L., Alizadeh, D., Van Handel, M., Kortylewski, M., Yu, H., and Badie, B. (2009) Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice Glia 57, 1458-1467
40. Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., Deng, J., Soifer, H. S., Raubitschek, A., Forman, S., Rossi, J. J., Pardoll, D. M., Jove, R., and Yu, H. (2009) In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses Nat. Biotechnol. 27, 925-932
41. Wang, Y. H., Hou, Y. W., and Lee, H. J. (2007) An intracellular delivery method for siRNA by an arginine-rich peptide J. Biochem. Biophys. Methods 70, 579-586
42. Kumar, P., Wu, H., McBride, J. L., Jung, K. E., Kim, M. H., Davidson, B. L., Lee, S. K., Shankar, P., and Manjunath, N. (2007) Transvascular delivery of small interfering RNA to the central nervous system Nature 448, 39-43 (Pubitemid 47037001)
43. El-Sayed, A., Khalil, I. A., Kogure, K., Futaki, S., and Harashima, H. (2008) Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape J. Biol. Chem. 283, 23450-23461
44. Kim, S. W., Kim, N. Y., Choi, Y. B., Park, S. H., Yang, J. M., and Shin, S. (2010) RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system J. Controlled Release 143, 335-343
45. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 97, 13003-13008
46. Westwood, J. A., Smyth, M. J., Teng, M. W., Moeller, M., Trapani, J. A., Scott, A. M., Smyth, F. E., Cartwright, G. A., Power, B. E., Honemann, D., Prince, H. M., Darcy, P. K., and Kershaw, M. H. (2005) Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice Proc. Natl. Acad. Sci. U.S.A. 102, 19051-19056 (Pubitemid 43049564)
47. Lee, F. T., Mountain, A. J., Kelly, M. P., Hall, C., Rigopoulos, A., Johns, T. G., Smyth, F. E., Brechbiel, M. W., Nice, E. C., Burgess, A. W., and Scott, A. M. (2005) Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A″-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478 Clin. Cancer Res. 11, 7080s-7086s (Pubitemid 41428708)
48. de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P., and Van Hoof, F. (1974) Commentary. Lysosomotropic agents Biochem. Pharmacol. 23, 2495-2531
49. Erbacher, P., Roche, A. C., Monsigny, M., and Midoux, P. (1996) Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes Exp. Cell Res. 225, 186-194 (Pubitemid 26158468)
50. Alimoghaddam, K. (2002) Effect of chloroquine on transduction of cell lines and baboon CD34 cells by a GALV pseudotyped retrovirus Arch. Iran. Med. 5, 244-250 (Pubitemid 36150450)
51. Zhang, H., Solomon, V. R., Hu, C., Ulibarri, G., and Lee, H. (2008) Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives Biomed. Pharmacother. 62, 65-69 (Pubitemid 351215807)
52. Bonner, J. A., Trummell, H. Q., Willey, C. D., Plants, B. A., and Raisch, K. P. (2009) Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma Radiother. Oncol. 92, 339-344
53. Kim, D. H., Behlke, M. A., Rose, S. D., Chang, M. S., Choi, S., and Rossi, J. J. (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy Nat. Biotechnol. 23, 222-226 (Pubitemid 40255333)
54. Amarzguioui, M. and Rossi, J. J. (2008) Principles of Dicer substrate (D-siRNA) design and function Methods Mol. Biol. 442, 3-10